News | Balloon Catheter | February 15, 2022

CERENOVUS Launches EMBOGUARD Balloon Guide Catheter to Use In the Treatment of Acute Ischemic Stroke

EMBOGUARD is the first balloon guide catheter from CERENOVUS and is the latest device to join the CERENOVUS Stroke Solutions suite of technologies.


February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies, has announced the launch of EMBOGUARD, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

Ischemic strokes, caused by the formation of a local blood clot or an embolus that travels to a vessel in the brain and obstructs blood supply, account for 85%1 of all strokes worldwide. Mechanical thrombectomy (MT), a minimally invasive procedure to remove a clot, is the recommended treatment option for acute ischemic stroke.2 The EMBOGUARD Balloon Guide Catheter is designed to optimize removal of clots by controlling blood flow locally during MT procedures.3 Balloon guide catheters increase first pass recanalization, reduce procedure time and reduce the odds of clot fragments breaking off and causing distal emboli.4 Distal emboli in an endovascular procedure can result in new ischemic events.

“Without timely and effective treatment of stroke, patients can suffer from lifelong disability or dependency,” said David Fiorella MD, PhD, Director of Cerebrovascular Center, Stony Brook University Hospital. “The benefits of balloon guide catheters are becoming increasingly recognized for their ability to maximize patient outcomes. By adding this innovation to their Stroke Solutions portfolio, CERENOVUS will be arming physicians with the tools they need to better serve our patients, potentially increasing the chances to live a functional and fulfilling life post-stroke.”

EMBOGUARD is the latest addition to join CERENOVUS Stroke Solutions - a suite of technologies designed with compatibility in mind to assist physicians in performing mechanical thrombectomy procedures. Launched in 2020, CERENOVUS Stroke Solutions now includes the EMBOTRAP III Revascularization Device, the PROWLER™ EX Microcatheter, the CERENOVUS™ Large Bore Catheter as well as both the EMBOGUARD Balloon Guide Catheter and the CEREBASE Guide Sheath.

“We’re proud to announce the addition of EMBOGUARD into our family of CERENOVUS Stroke Solutions,” said Mark Dickinson, Worldwide President, CERENOVUS. “The addition of this device to our portfolio of technologies provides physicians with an innovative and comprehensive set of tools to treat their patients, building on our commitment to changing the trajectory of stroke.”

Reference:

  1. Ischaemic stroke. Stroke Association. Stroke.org.uk. www.stroke.org.uk.
  2. Parthasarathy R and Gupta V. Ann Indian Acad Neurol. 2020 Jan-Feb 23(1): 13–19. www.ncbi.nlm.nih.gov. Last accessed online September 2020.
  3. EMBOGUARD Simulated Clot Retrieval Report. 500756583 | Rev: A.6. Released: 15-Jul-2021. State: Released. CN: 231147
  4. Brinjikji, Waleed, et al. Impact of balloon guide catheter on technical and clinical outcomes: a systematic review and metaanalysis. J NeuroIntervent Surg. 2017. jnis.bmj.com.

 


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
Subscribe Now